Literature DB >> 1893816

Chronic mitoinhibition during promotion of hepatocarcinogenesis.

E Laconi1, P M Rao, S Rajalakshmi, P Pani, D S Sarma.   

Abstract

We have reported previously that orotic acid (OA), a precursor for pyrimidine nucleotide biosynthesis, is able to promote carcinogenic process in both liver and duodenum of rats. The present study investigates the possible role of mitoinhibitory effects of OA as being responsible for its promotional effects. Male Fischer 344 rats were given a semisynthetic basal diet (BD) or a diet containing 1% OA for four weeks coupled with 2/3 partial hepatectomy (PH), and all animals were then continued on BD for an additional four weeks. This protocol is known to exert a promoting effect on the initiated rat liver. Livers were perfused, and the labeling index (LI) of isolated cultured hepatocytes was monitored. Hepatocytes isolated from livers of rats fed a BD or 1% OA exhibited in vitro an LI of 39 +/- 2 and 24 +/- 1%, respectively. The lowered in vitro LI was seen even upon exposure to epidermal growth factor (EGF) (67 +/- 2% in OA-treated livers compared to 91 +/- 2% in hepatocytes from control rat liver). A similar four-week exposure to OA coupled with PH decreased hepatic DNA synthesis induced by a choline-deficient diet in vivo by about 50%. These results indicate that OA is able to decrease the response of normal hepatocytes to growth factors and suggest a possible mechanism of chronic differential mitoinhibition as a basis for promotion induced by OA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1893816     DOI: 10.1007/bf01307525

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

Review 2.  Regulation of hepatic growth.

Authors:  M R Alison
Journal:  Physiol Rev       Date:  1986-07       Impact factor: 37.312

3.  Studies on the mitoinhibitory effect of orotic acid on hepatocytes in primary culture.

Authors:  G Pichiri-Coni; P Coni; E Laconi; P E Schwarze; P O Seglen; P M Rao; S Rajalakshmi; D S Sarma
Journal:  Carcinogenesis       Date:  1990-06       Impact factor: 4.944

4.  Liver cell turnover in rats fed a choline-devoid diet.

Authors:  N Chandar; J Amenta; J C Kandala; B Lombardi
Journal:  Carcinogenesis       Date:  1987-05       Impact factor: 4.944

Review 5.  Liver tumour promotion by chemicals: models and mechanisms.

Authors:  D S Sarma; P M Rao; S Rajalakshmi
Journal:  Cancer Surv       Date:  1986

6.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Promotion by orotic acid of liver carcinogenesis in rats initiated by 1,2-dimethylhydrazine.

Authors:  C Laurier; M Tatematsu; P M Rao; S Rajalakshmi; D S Sarma
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

8.  Dietary orotic acid enhances the incidence of gamma-glutamyltransferase positive foci in rat liver induced by chemical carcinogens.

Authors:  P M Rao; K Nagamine; R K Ho; M W Roomi; C Laurier; S Rajalakshmi; D S Sarma
Journal:  Carcinogenesis       Date:  1983-12       Impact factor: 4.944

9.  Inhibition of DNA synthesis in primary cultures of hepatocytes by orotic acid.

Authors:  E Laconi; F Li; E Semple; P M Rao; S Rajalakshmi; D S Sarma
Journal:  Carcinogenesis       Date:  1988-04       Impact factor: 4.944

10.  Promotion of liver carcinogenesis in the rat by a choline-devoid diet: role of liver cell necrosis and regeneration.

Authors:  L I Giambarresi; S L Katyal; B Lombardi
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more
  1 in total

1.  Orto-aminoazotoluen induces the expression of the p53 gene in inbred strains of mice susceptible and resistant to hepatocarcinogenesis.

Authors:  O A Timofeeva; A V Eremeev; A N Goloshchapov; S I Ilnitskaya; T I Merculova; V I Kaledin; N A Setkov
Journal:  Dokl Biol Sci       Date:  2009 Nov-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.